Squarepoint’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120,786
| Closed | -$309K | – | 3107 |
|
|
2025
Q1 | $309K | Buy |
120,786
+46,846
| +63% | +$120K | ﹤0.01% | 2179 |
|
|
2024
Q4 | $139K | Buy |
73,940
+18,522
| +33% | +$34.8K | ﹤0.01% | 2468 |
|
|
2024
Q3 | $56.5K | Sell |
55,418
-82,346
| -60% | -$84K | ﹤0.01% | 2424 |
|
|
2024
Q2 | $161K | Buy |
137,764
+119,949
| +673% | +$140K | ﹤0.01% | 2192 |
|
|
2024
Q1 | $22.4K | Buy |
+17,815
| New | +$22.4K | ﹤0.01% | 2365 |
|
|
2021
Q1 | – | Sell |
-22,068
| Closed | -$80K | – | 2940 |
|
|
2020
Q4 | $80K | Sell |
22,068
-22,611
| -51% | -$82K | ﹤0.01% | 2373 |
|
|
2020
Q3 | $173K | Buy |
+44,679
| New | +$173K | ﹤0.01% | 1989 |
|